Ledger.Open graph →
SEC Form D · filed March 16, 2023

Shennon Biotechnologies Inc

Offering
$7.3M
Sold
$7.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

James Hardiman · St. John's, Newfoundland and Labrador, CanadaDirectorLi Sun · SAN FRANCISCO, CAExec · DirectorJames Hardiman · St. John's, Newfoundland and Labrador, CanadaDirectorLi Sun · SAN FRANCISCO, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗